Navigation

    REAN Foundation

    • Register
    • Login
    • Search
    • Categories
    • Unread
    • Recent
    • Tags
    • Popular
    • Admin

    CV Risk Biomarkers Tentatively Identified in Psoriatic Disease

    Dermatology & Cosmetic Care
    2
    2
    1
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • M
      MINTI last edited by

      The risk of cardiovascular events in patients with psoriatic disease rises with higher levels of two cardiac biomarkers in a manner independent of risk calculated by the Framingham Risk Score (FRS), a longitudinal cohort study has shown. But researchers who conducted the study note that neither of the two biomarkers identified in the study ― cardiac troponin I (cTnI) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) ― led to an improvement in predictive performance when combined with the FRS, despite their association with carotid plaque burden.

      D 1 Reply Last reply Reply Quote 0
      • D
        DEBMOY @MINTI last edited by

        @minti Psoriasis and psoriatic arthritis are both associated with greater risk of cardiovascular morbidity and mortality, partly because of systemic inflammation that leads to atherogenesis. Measures of cardiovascular risk such as the FRS rely on traditional measures of cardiovascular risk and thus are likely to underestimate the cardiovascular event risk of people with psoriatic disease

        1 Reply Last reply Reply Quote 0
        • First post
          Last post